Literature DB >> 21850331

Vectorized ferrocenes with estrogens and vitamin D2: synthesis, cytotoxic activity and docking studies.

José Vera1, Li Ming Gao, Alberto Santana, Jaime Matta, Enrique Meléndez.   

Abstract

Three ferrocene complexes vectorized with estrogens and vitamin D(2) were synthesized and fully characterized by spectroscopic, electrochemical and computational methods. The synthesis of these esters was accomplished by reacting ferrocenoyl chloride with the corresponding ROH groups (R = ergocalciferol, estradiol, estrone). The cytotoxicity of these complexes in HT-29 colon cancer and MCF-7 breast cancer cell lines was investigated in vitro. Only ferrocenoyl 17β-hydroxy-estra-1,3,5(10)-trien-3-olate showed good cytotoxic activity in both cell lines, exceeding those of ferrocenium and ferrocene. In MCF-7, ferrocenoyl 17β-hydroxy-estra-1,3,5(10)-trien-3-olate exhibited remarkable IC(50), in the low micromolar range. This may be attributed to the presence of the estradiol vector. Docking studies between alpha-estrogen receptor ligand binding site and ferrocenoyl 17β-hydroxy-estra-1,3,5(10)-trien-3-olate revealed some key hydrophobic interactions that might explain the cytotoxic activity of this ester.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21850331      PMCID: PMC4461443          DOI: 10.1039/c1dt10995b

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  19 in total

1.  Vitamin D and prevention of colorectal cancer.

Authors:  Edward D Gorham; Cedric F Garland; Frank C Garland; William B Grant; Sharif B Mohr; Martin Lipkin; Harold L Newmark; Edward Giovannucci; Melissa Wei; Michael F Holick
Journal:  J Steroid Biochem Mol Biol       Date:  2005-10-19       Impact factor: 4.292

2.  Recent applications of chiral ferrocene ligands in asymmetric catalysis.

Authors:  Ramón Gómez Arrayás; Javier Adrio; Juan Carlos Carretero
Journal:  Angew Chem Int Ed Engl       Date:  2006-11-27       Impact factor: 15.336

3.  Three-dimensional models of estrogen receptor ligand binding domain complexes, based on related crystal structures and mutational and structure-activity relationship data.

Authors:  J M Wurtz; U Egner; N Heinrich; D Moras; A Mueller-Fahrnow
Journal:  J Med Chem       Date:  1998-05-21       Impact factor: 7.446

4.  Water stability and cytotoxic activity relationship of a series of ferrocenium derivatives. ESR insights on the radical production during the degradation process.

Authors:  Giovanni Tabbì; Claudio Cassino; Giorgio Cavigiolio; Donato Colangelo; Annalisa Ghiglia; Ilario Viano; Domenico Osella
Journal:  J Med Chem       Date:  2002-12-19       Impact factor: 7.446

5.  The Conformations of 17β-Estradiol (E2) and 17α-Estradiol as Determined by Solution NMR.

Authors:  Jianxin Guo; Richard I Duclos; V Kiran Vemuri; Alexandros Makriyannis
Journal:  Tetrahedron Lett       Date:  2010-07-07       Impact factor: 2.415

Review 6.  Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects.

Authors:  Anne Vessières; Siden Top; Wolfgang Beck; Elizabeth Hillard; Gérard Jaouen
Journal:  Dalton Trans       Date:  2005-09-27       Impact factor: 4.390

7.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability.

Authors:  F Denizot; R Lang
Journal:  J Immunol Methods       Date:  1986-05-22       Impact factor: 2.303

8.  Ferricenium complexes: a new type of water-soluble antitumor agent.

Authors:  P Köpf-Maier; H Köpf; E W Neuse
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 9.  The nuclear receptor superfamily: the second decade.

Authors:  D J Mangelsdorf; C Thummel; M Beato; P Herrlich; G Schütz; K Umesono; B Blumberg; P Kastner; M Mark; P Chambon; R M Evans
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

10.  Synthesis, structure, electrochemistry, and cytotoxic properties of ferrocenyl ester derivatives.

Authors:  Li Ming Gao; Ramón Hernández; Jaime Matta; Enrique Meléndez
Journal:  Met Based Drugs       Date:  2009-03-24
View more
  8 in total

1.  Ferrocenes as potential chemotherapeutic drugs: synthesis, cytotoxic activity, reactive oxygen species production and micronucleus assay.

Authors:  Wanda I Pérez; Yarelys Soto; Carmen Ortíz; Jaime Matta; Enrique Meléndez
Journal:  Bioorg Med Chem       Date:  2014-12-19       Impact factor: 3.641

2.  Steroidal ferrocenes as potential enzyme inhibitors of the estrogen biosynthesis.

Authors:  Bianka Edina Herman; János Gardi; János Julesz; Csaba Tömböly; Eszter Szánti-Pintér; Klaudia Fehér; Rita Skoda-Földes; Mihály Szécsi
Journal:  Biol Futur       Date:  2020-06-25

3.  Functionalized ferrocenes: The role of the para substituent on the phenoxy pendant group.

Authors:  José L Vera; Jorge Rullán; Natasha Santos; Jesús Jiménez; Joshua Rivera; Alberto Santana; Jon Briggs; Arnold L Rheingold; Jaime Matta; Enrique Meléndez
Journal:  J Organomet Chem       Date:  2014-01-01       Impact factor: 2.369

4.  New tungstenocenes containing 3-hydroxy-4-pyrone ligands: antiproliferative activity on HT-29 and MCF-7 cell lines and binding to human serum albumin studied by fluorescence spectroscopy and molecular modeling methods.

Authors:  Moralba Domínguez-García; Carlos Ortega-Zúñiga; Enrique Meléndez
Journal:  J Biol Inorg Chem       Date:  2012-12-05       Impact factor: 3.358

5.  Metallocenes as Target Specific Drugs for Cancer Treatment.

Authors:  Enrique Meléndez
Journal:  Inorganica Chim Acta       Date:  2012-06-21       Impact factor: 2.545

6.  Crystal structure of bis-[4-(1H-pyrrol-1-yl)phen-yl] ferrocene-1,1'-di-carboxyl-ate: a potential chemotherapeutic drug.

Authors:  Wanda I Pérez; Arnold L Rheingold; Enrique Meléndez
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-04-22

7.  Crystal structure of 16-ferrocenylmethyl-3β-hydroxy-estra-1,3,5(10)-trien-17-one: a potential chemotherapeutic drug.

Authors:  José A Carmona-Negrón; Mariola M Flores-Rivera; Zaibeth Díaz-Reyes; Curtis E Moore; Arnold L Rheigold; Enrique Meléndez
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2016-05-27

8.  Antimicrobial activity of RP-1 peptide conjugate with ferrocene group.

Authors:  Natalia C S Costa; Julia P Piccoli; Norival A Santos-Filho; Leandro C Clementino; Ana M Fusco-Almeida; Sarah R De Annunzio; Carla R Fontana; Juliane B M Verga; Silas F Eto; João M Pizauro-Junior; Marcia A S Graminha; Eduardo M Cilli
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.